Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details 1)

v3.22.2.2
NOTES PAYABLE (Details 1)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Equity_Instrument
$ / shares
Dec. 31, 2021
USD ($)
Equity_Instrument
$ / shares
Debt Instrument [Line Items]    
Principal Outstanding $ 29,421 $ 22,339
Unamortized Discount 3,273 4,332
Carrying Amount $ 26,143 $ 18,007
Underlying Shares Notes | Equity_Instrument 41,432,198 10,173,099
Convertible notes payable, current $ 14,346 $ 10,158
2021 Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Interest rate [1] 2.00% 2.00%
Term of Notes [1] 3 years 3 years
Conversion Price | $ / shares [1] $ 0.37 $ 1.48
Principal Outstanding [1] $ 14,315 $ 14,490
Unamortized Discount [1] 3,119 4,332
Carrying Amount [1] $ 11,196 $ 10,158
Underlying Shares Notes | Equity_Instrument [1] 41,112,131 9,856,343
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Principal Outstanding $ 17,465 $ 17,640
Unamortized Discount 3,119 4,332
Carrying Amount $ 14,346 $ 13,308
Underlying Shares Notes | Equity_Instrument 41,432,198 10,173,099
Principal Outstanding, Current $ 17,465 $ 14,490
Unamortized Discount, Current 3,119 4,332
Convertible notes payable, current $ 14,346 $ 10,158
Underlying Shares Notes, Current | Equity_Instrument 41,432,198 9,856,343
Principal Outstanding, Non Current   $ 3,150
Notes payable, non-current   $ 3,150
Underlying Shares Notes, Non Current | Equity_Instrument   316,756
2020 Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Interest rate [2] 12.00% 12.00%
Term of Notes [2] 3 years 3 years
Conversion Price | $ / shares [2] $ 10.00 $ 10.00
Principal Outstanding [2] $ 3,150 $ 3,150
Carrying Amount [2] $ 3,150 $ 3,150
Underlying Shares Notes | Equity_Instrument [2] 320,067 316,756
Notes payable - related parties [Member]    
Debt Instrument [Line Items]    
Principal Outstanding $ 6,301 $ 800
Unamortized Discount 135  
Carrying Amount 6,161 800
Principal Outstanding, Current 2,780 $ 800
Principal Outstanding, Non Current 3,521  
Unamortized Discount, Non Current 135  
Notes payable, non-current $ 3,381  
[1]

The notes are convertible into shares of common stock of Emmaus Life Sciences, Inc. Beginning February 28, 2022, the note holders became entitled to call for redemption of the convertible notes payable at any time. Accordingly, the notes are classified as current liabilities.
[2] This note is convertible into shares of EMI Holding, Inc., a wholly owned subsidiary of Emmaus Life Sciences, Inc.